Member Info for Troutisout1

There's hardly any sells, there is a 56k rollover in the sell column, other than that it is the sort of trade size you obviously deal in, as you seem so impressed.

The trade here is very quiet, with low turnover of shares (hence the MMs moving the SP around as much as they have)

As an investor, I can confirm that I have neither lost trust or faith in the Company, if some feel they have, then they need to consider their investment here.

Posting in a BB is not going to change anything, the news will arrive when it is ready, as always patience is required even more with Medical companies.

OSD, you have two of Laura's beloved TR1s selling out and both will use this opportunity to do some more selling...

There were 660m shares issued in the placing and wrap offering at 1p, so if there is lots of buying and the price stands still, it is likely someone is offloading a few million.

Can't even buy 1k shares now....

Some weird maths going on here....

Well looks like someone is buying in large amounts

There aren't many small AIM companies that get research notes on them, from anyone other than their own broker.

Steve, it looks like those 5m trades were cancelled and changed to 500k trades

Laura, why don't you post the whole sentence, rather than miss some of it out? Do you think the term 'initial assessment' make the rest of the statement a bit flimsy? Also as pointed out before over the last few years, a company doesn't wait until the cash runs out to raise, they have to do it earlier or suffer big discounts when they do raise. So with the board's initial assessment stating enough cash until 2027 and a need to raise a few months before cash runs out, gives us 4to 5 months at best! Now you can post as much as you like, but a look back on here will see how you and others got it so wrong previous times with timing of raises. On this you have been consistently wrong!

"The Board's initial assessment of Physiomics' balance sheet is that there is a sufficient cash runway into 2027"

So at the moment, the quotes for 100k each way are sell for 13.33p and buy at 14.38p, that's over a penny spread and way too big. The MMs don't want any trade...

There is no evidence of that and a little prospect as well...We have a seller at the moment and yesterday they were throwing lots out, when they have finished this will recover and some will have added at a decent entry.

There was me thinking that the new team were getting rid of consultants, whose fees drained the finances? They were meant to be able with all their experience do without consultancy fees hence the new BoD's larger remuneration when share payments are included? That was what everyone was saying on this BB. Mind you people posting here have flipped from blind faith in the last BoD to now blind faith in the new BoD, so doesn't surprise me to see them change from saying consultants were costly and bad to now trying to hail a new costly consultant.

As some have said below the proof is in the pudding and that means contracts and revenue booked, I still see a fundraise this calender year and guess what, there won't be a second set of activist investors insisting the next one is held at a higher price....

Looking good here, the ducks are lining up nicely, I am sure our patience will be rewarded handsomely.

Rusty,

Reading your posts you seem to be having the same head versus heart conundrum. Can I just say that bringing up CF after all this time is pointless, this is a different company without him. What happened in the US would and has affected many companies in the Pharma/Biotech arena and they are the Hvivo's HCT clients. That was a very external failure and to some extent shareholders haven't given the BoD the due appreciation for actually diversifying the Company's revenue stream with the acquisitions.

Just as some can hang on to too much positivity when a stock re-rates downwards, some can hang on to the negativity too long when it turns up.

I always try and look at it as, if I wasn't an investor would I buy into it or another company at this time, if I would then it is a hold/buy, if not then likely to be a sell option.

So the RNS has come, if you read it without rose tinted glasses, it has some words that don't need to be in there but are, and that is what you should concentrate on,

Words like "what appears to be", don't give the statement the same certainty as without their addition.

Then we go to " the aggregate cash cost of the Company's Board remuneration arrangements" statement, again the addition of 'cash' in that statement means that they will cost more than the previous board but this will be paid in shares (ultimately diluting current shareholders).

They talk of other opportunities, "which may materially enhance the Company's medium-term prospects", the words that stand out are 'may' and 'medium-term', then later on we have "and long-term value creation for shareholders", these statements are all caveated by certain words and there seems a realisation that nothing is going to be happening much in the short term. I suspect they will finish their review and then issue a 'kitchen sink' statement and go for a fundraise.

They mention payments, but I would expect senior Directors to have some sort of notice period that will need paying off and 6 months doesn't seem far from what I would expect as a Director's notice period, so although they confirm no extra payments, there will still be some eating into the cash pile.

Finally, if Ian Bagnall is now going to be an Executive Director, do we not need an RNS noting his previous appointments and any other current ones?

This was a holding statement and one I suspect shows they have found some surprises and are having to put a positive spin on, but without any definitive language.

Caveat Emptor, there are a lot that jumped in for a quick buck here and they will want an exit soon, but PYC has always been great in turning short term investors into loss-making stale bulls.

I think this will move back up shortly, only got 60k on the offer, going NT on anything over that. Yet can sell 250k. DYOR!

Not sure how the contracts shift the needle, when the needle seems to be disconnected by other things and investor emotions.

Quite a lot of negativity has crept in here, that will shift as people move on. My main bugbear is the IIs and that constantly weighs on the SP, are they selling, holding or buying, sometimes it looks like they don't even know!

HVO has had a really bad time, but is now showing signs of improvement, the two large HCTs have set the way, I posted a few weeks back that as more HCT contracts get signed and announced, those in the queue with their own HCT need to stop trying to get the best deal and now sign up and get a date in, before the diary for Canary Wharf fills up. Time is money and as the Quarantine facility gets booked up, those on the fence will end up with longer timescales.

Https://www.sec.gov/ix?doc=/Archives/edgar/data/0002093507/000182912626004284/greenlandenergy_8k.htm

They've got to have time to 'kitchen sink' it, the new BoD will understandably want to announce and blame the previous Management for all the skeletons in the cupboard and there will be a few. Then after that reset, they can start afresh...

Good to see the amended RNS last night ;o)